Home › Prostate Cancer › Texas › Fort Worth
Prostate Cancer clinical trials in Fort Worth, TX
9 studies for Prostate Cancer are looking for participants at sites in and around Fort Worth (within about 30 miles). Open a study to see who can join and how to contact the study team.
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RecruitingPhase 2
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
RecruitingPhase 1
- START Dallas-Fort Worth, Fort Worth
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
RecruitingPhase 3
- University of Texas Southwestern Simmons Cancer Center - Fort Worth, Fort Worth
A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)
RecruitingPhase 3
- Urology Partners of North Texas (UPNT), Fort Worth
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
RecruitingPhase 3
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
RecruitingPhase 2
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
RecruitingPhase 3
- Tarrant County Hospital District/JPS Health Network, Fort Worth
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
RecruitingPhase 1
- START Dallas, Fort Worth
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
RecruitingPhase 3
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
About Prostate Cancer
Prostate cancer is one of the most common types of cancer among American men. The risk goes up as men age. Learn about symptoms, tests, and treatment.
More about Prostate Cancer on MedlinePlus
Prostate Cancer trials in other cities
- New York City, NY103 studies
- Houston, TX76 studies
- Los Angeles, CA61 studies
- Boston, MA60 studies
- St. Louis, MO47 studies
- San Francisco, CA45 studies
- Chicago, IL45 studies
- Seattle, WA44 studies
- Philadelphia, PA44 studies
- Nashville, TN43 studies
- Baltimore, MD42 studies
- Washington, DC38 studies
Other studies in Fort Worth
- Non-Small Cell Lung Cancer18 studies
- Ovarian Cancer17 studies
- Endometrial Cancer13 studies
- Breast Cancer11 studies
- Cancer (all types)10 studies
- Metastatic Cancer7 studies
- Macular Degeneration7 studies
- Heart Failure7 studies
- Kidney Cancer (Renal Cell Carcinoma)7 studies
- Triple-Negative Breast Cancer7 studies
- Colorectal Cancer7 studies
- Obesity6 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.